The Role of the Insulin-like Growth Factor System in Human Cancer

作者: Haim Werner , Derek LeRoith

DOI: 10.1016/S0065-230X(08)60354-1

关键词:

摘要: Publisher Summary This chapter focuses on the role of insulin-like growth factor system in human cancer. The normal process and differentiation results from genetically programmed action a number different cellular extracellular factors. Derangement function one or more those agents can result pathologic phenotype, including neoplastic growth. A family factors shown to be intimately involved regulation cell as well transformation is (IGF) family. IGF-I IGF-II are mitogenic polypeptides produced largest amounts by liver secreted into circulation, where they mediate effects hormone (GH) longitudinal In addition ligands receptors, IGF comprises third category molecules, which bind IGFs circulation compartments. Six IGF-binding proteins (IGFBPs) have been characterized date. Binding receptor induces autophosphorylation. cycle consists four major phases: (1) presynthetic phase, G; (2) phase DNA synthesis, S; (3) premitotic (4) mitosis, M. IGF-I, IGF-II, insulin chemotactic for melanoma line A2058, assayed modified Boyden chamber. also gives selected examples involvement wealth information generated field, continued research efforts, both basic clinic, promise produce rational therapeutic approaches cancers involved.

参考文章(256)
Ira D. Goldfine, Biancamaria Gliozzo, Vincenzo Papa, Riccardo Vigneri, Dan Moore, William L. McGuire, Gary M. Clark, Yoko Fujita-Yamaguchi, Vincenzo Pezzino, Insulin-like Growth Factor-I Receptors Are Overexpressed and Predict a Low Risk in Human Breast Cancer Cancer Research. ,vol. 53, pp. 3736- 3740 ,(1993)
Z Pietrzkowski, C Sell, R Lammers, A Ullrich, R Baserga, Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Molecular and Cellular Biology. ,vol. 12, pp. 3883- 3889 ,(1992) , 10.1128/MCB.12.9.3883
P Porcu, A Ferber, Z Pietrzkowski, C T Roberts, M Adamo, D LeRoith, R Baserga, The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor. Molecular and Cellular Biology. ,vol. 12, pp. 5069- 5077 ,(1992) , 10.1128/MCB.12.11.5069
Caterina P. Minniti, Lee J. Helman, Mario Maggi, Suramin Inhibits the Growth of Human Rhabdomyosarcoma by Interrupting the Insulin-like Growth Factor II Autocrine Growth Loop Cancer Research. ,vol. 52, pp. 1830- 1835 ,(1992)
X J Sun, D L Crimmins, M G Myers, M Miralpeix, M F White, Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 Molecular and Cellular Biology. ,vol. 13, pp. 7418- 7428 ,(1993) , 10.1128/MCB.13.12.7418
A. Ullrich, A. Gray, A.W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. The EMBO Journal. ,vol. 5, pp. 2503- 2512 ,(1986) , 10.1002/J.1460-2075.1986.TB04528.X
Jos� A. Figueroa, Jivesh Sharma, James G. Jackson, Martin J. McDermott, Susan G. Hilsenbeck, Douglas Yee, Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells Journal of Cellular Physiology. ,vol. 157, pp. 229- 236 ,(1993) , 10.1002/JCP.1041570204
Q. Ren-Qiu, T. Ruelicke, S. Hassam, G. K. Haselbacher, E. J. Schoenle, Systemic effects of insulin-like growth factor-II produced and released from Wilms tumour tissue European Journal of Pediatrics. ,vol. 152, pp. 102- 106 ,(1993) , 10.1007/BF02072483
Marja J. C. Steenman, Shirley Rainier, Craig J. Dobry, Paul Grundy, Isabelle L. Horon, Andrew P. Feinberg, Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour Nature Genetics. ,vol. 7, pp. 433- 439 ,(1994) , 10.1038/NG0794-433